Opinion|Videos|April 30, 2024
Optimizing Care for Newly Diagnosed Hepatic Encephalopathy
Medical experts discuss the challenges of starting treatment for newly diagnosed, cognitively impaired patients, addressing prescription processes, patient education, and the role of cost, care quality, and convenience in promoting successful medication adherence.
Advertisement
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Related Articles
- Additional Considerations With PBC Therapies
February 5th 2025
- Monitoring Patients Transitioning From Obeticholic Acid
January 29th 2025
- Best Practices in Switching PBC Therapies
January 29th 2025
- Long-Term Safety of Second-Line Therapies for PBC
January 22nd 2025
- Additional Safety Considerations With PBC Treatments
January 15th 2025
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times - Pharmacy Practice News and Expert Insights
1
IMS 2025: Quadruplet Regimens Enhance Depth of Response in Multiple Myeloma
2
Updated IMWG Guidelines Spotlight MRD, Functional Imaging, and Light Chain Assays in Multiple Myeloma
3
IMS 2025: Future Directions for CAR T Therapy in Relapsed and Refractory Multiple Myeloma
4
FDA Approves Bosaya and Aukelso, Biosimilars to Reference Denosumab
5